Capital International LTD Moderna, Inc. Transaction History

Capital International LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $502,440 - $680,647	-4,240 Reduced 31.25%	9,330 $1.13 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $713,435 - $1.04 Million	5,259 Added 63.28%	13,570 $2.08 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $983,856 - $1.75 Million	8,311 New	8,311 $1.49 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $880,414 - $1.64 Million	-6,962 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $1.15 Million - $1.87 Million	5,088 Added 271.5%	6,962 $1.77 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $20,858 - $45,540	-94 Reduced 4.78%	1,874 $721,000
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $1.06 Million - $1.91 Million	-8,129 Reduced 80.51%	1,968 $462,000
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $1.1 Million - $1.88 Million	10,097 New	10,097 $1.32 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

Stay updated on Capital International LTD with notifications on news.